Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium.

doi:10.1038/bjc.2017.231

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium.

British journal of cancer - 22 Aug 2017

Lophatananon Artitaya, Stewart-Brown Sarah, Kote-Jarai Zsofia, Olama Ali Amin Al, Garcia Sara Benlloch, Neal David E, Hamdy Freddie C, Donovan Jenny L, Giles Graham G, Fitzgerald Liesel M, Southey Melissa C, Pharoah Paul, Pashayan Nora, Gronberg Henrik, Wiklund Fredrik, Aly Markus, Stanford Janet L, Brenner Hermann, Dieffenbach Aida K, Arndt Volker, Park Jong Y, Lin Hui-Yi, Sellers Thomas, Slavov Chavdar, Kaneva Radka, Mitev Vanio, Batra Jyotsna, Spurdle Amanda, Clements Judith A, Easton Douglas, Eeles Rosalind A, Muir Kenneth

Abstract excerpt

BACKGROUND: Evidence on height and prostate cancer risk is mixed, however, recent studies with large data sets support a possible role for its association with the risk of aggressive prostate cancer. METHODS: We analysed data from the PRACTICAL consortium consisting of 6207 prostate cancer cases and 6016 controls and a subset of high grade cases (2480 cases). We explored height, polymorphisms in genes related to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Body Height

Share to Case-Control Studies

Share to Gene-Environment Interaction

Share to Neoplasm Grading

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 28765617
DOI: 10.1038/bjc.2017.231
PMCID: PMC5572182

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Height, selected genetic markers and prostate cancer risk: results from the PRACTICAL consortium.PMID 28765617Read ↗

The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium.Semantic proximity Read ↗

Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses.Semantic proximity Read ↗

Appraising causal relationships of dietary, nutritional and physical-activity exposures with overall and aggressive prostate cancer: two-sample Mendelian-randomization study based on 79 148 prostate-cancer cases and 61 106 controlsSemantic proximity Read ↗

Pleiotropy between genetic markers of obesity and risk of prostate cancer.Semantic proximity Read ↗

Insights and Implications of Genome-Wide Association Studies of HeightSemantic proximity Read ↗

Genome-wide association approaches for identifying loci for human height genes.Semantic proximity Read ↗

Association Between the Body Mass Index and Prostate Cancer at Biopsy is Modified by Genetic Risk: A Cross-Sectional Analysis in China.Semantic proximity Read ↗

Sport, genetic susceptibility, and the risk of benign prostatic hyperplasia: a large prospective cohort study.Semantic proximity Read ↗

A genome-wide pleiotropy scan for prostate cancer risk.Semantic proximity Read ↗

Circulating free testosterone and risk of aggressive prostate cancer: Prospective and Mendelian randomisation analyses in international consortiaSemantic proximity Read ↗

Germline genetic variation in prostate susceptibility does not predict outcomes in the chemoprevention trials PCPT and SELECT.Semantic proximity Read ↗

Pubertal development and prostate cancer risk: Mendelian randomization study in a population-based cohort.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.